東光化工(01702.HK)上半年純利增加約20.5%至8980萬元
格隆匯8月27日丨東光化工(01702.HK)公吿,於2024年上半年,即使面臨市場的重重挑戰,集團仍成功實施多項策略,維持競爭力及增長潛力,並取得穩健業績,展現強勁市場表現及技術實力。集團純利由截至2023年6月30日止六個月的約人民幣74.5百萬元增加約人民幣15.3百萬元或20.5%至報吿期間的約人民幣89.8百萬元。集團純利的增加乃主要由於整體毛利及毛利率增加,而此乃主要由於原材料成本減少導致銷售成本減少所致。原材料成本減少乃主要由於報吿期間的煤炭(即生產集團尿素產品的主要原材料)的平均購買價格下降。
集團收入由截至2023年6月30日止六個月的約人民幣1,619.8百萬元減少約人民幣282.6百萬元或17.4%至報吿期間的約人民幣1,337.2百萬元,主要由於集團尿素產品的平均售價由2023年同期約每噸人民幣2,213元減少約8.8%至約每噸人民幣2,019元。此外,於報吿期間,集團車用尿素溶液產品的平均售價約每噸人民幣979元,較2023年同期約每噸人民幣1,876元減少約47.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.